Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18055472 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Abatacept (ABA) + Methotrexate (MTX), double-blind (DB);   Drug: Infliximab (INF) + MTX, DB;   Drug: Placebo (PLA) + MTX, DB;   Drug: PLA + MTX switched to ABA+ MTX, DB;   Drug: ABA, open-label (OL)

Indicates status has not been verified in more than two years